Real-time safety surveillance of seasonal influenza vaccines in children, Australia, 2015
A Pillsbury, P Cashman, A Leeb, A Regan, D Westphal, T Snelling, C Blyth, N Crawford, N Wood, K Macartney
Eurosurveillance | EUR CENTRE DIS PREVENTION & CONTROL | Published : 2015
Increased febrile reactions in Australian children from one influenza vaccine brand in 2010 diminished confidence in influenza immunisation, highlighting the need for improved vaccine safety surveillance. AusVaxSafety, a national vaccine safety surveillance system collected adverse events in young children for 2015 influenza vaccine brands in real time through parent/carer reports via SMS/email. Weekly cumulative data on 3,340 children demonstrated low rates of fever (4.4%) and medical attendance (1.1%). Fever was more frequent with concomitant vaccination.
AusVaxSafety surveillance was funded under a contract with the Australian Government Department of Health. We would like to thank the AusVaxSafety Steering Committee members for their contribution to oversight of the 2015 surveillance effort. We would also like to express our gratitude to the staff at our participating hospitals, clinics and general practices, as well as the parents/carers of children who participated in and supported 2015 AusVaxSafety surveillance.